-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280

Benzinga·10/20/2026 12:10:51
語音播報
Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.